SLS (SELLAS Life Sciences Group) Moat Score: 4/10 (As of Jun. 25, 2026)


SLS SELLAS Life Sciences Group Inc SLS
25 GF Score
Price $9.93
! 1 Warning Sign
View Full Analysis

What is SELLAS Life Sciences Group Moat Score?

SELLAS Life Sciences Group SLS +8.29% 25 Moat Score is 4 as of Jun. 25, 2026. GuruFocus rates SLS with a GF Score™ of 25/100. The stock has 1 warning sign investors should review. Among 1,405 Biotechnology companies, SELLAS Life Sciences Group ranks better than 88.83% on this metric.

SELLAS Life Sciences Group has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

SELLAS Life Sciences Group has Narrow Moat: SELLAS Life Sciences Group Inc has a discernible but modest moat due to its valuable intellectual property and ongoing R&D in the biotech sector. While it has potential for strong innovation, it lacks significant customer switching costs, brand strength, and regulatory barriers to be considered a strong narrow moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes SELLAS Life Sciences Group might have Narrow Moat - Discernible but modest moat.

SELLAS Life Sciences Group  (NAS:SLS) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

SELLAS Life Sciences Group Moat Score Related Terms

SLS vs SNDX, CAPR, AGIO: Moat Score Comparison

For the Biotechnology subindustry, SELLAS Life Sciences Group's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SELLAS Life Sciences Group Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SELLAS Life Sciences Group's Moat Score distribution charts can be found below:

* The bar in red indicates where SELLAS Life Sciences Group's Moat Score falls into.


SLS
25GF Score
SELLAS Life Sciences Group Inc SLS
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
SELLAS Life Sciences Group (SLS) has a Moat Score of 4 as of Jun. 25, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, SELLAS Life Sciences Group ranks #157 out of 1405 companies in the Biotechnology industry, placing it in the top 11.2%.
Is SELLAS Life Sciences Group's Moat Score too high?
SELLAS Life Sciences Group's current Moat Score is 4. The Biotechnology industry median Moat Score is 2.00. SELLAS Life Sciences Group's value of 4 is 100% above this industry median. Based on the distribution chart, SELLAS Life Sciences Group ranks #157 out of 1405 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, SELLAS Life Sciences Group has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does SELLAS Life Sciences Group's Moat Score compare to SNDX and CAPR?
According to the Biotechnology industry distribution chart, SELLAS Life Sciences Group ranks #157 out of 1405 companies for Moat Score. This places SELLAS Life Sciences Group in the top 11% of its industry — outperforming the majority of peers. The industry median Moat Score is 2.00. SELLAS Life Sciences Group's value of 4 is 100% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,405 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SELLAS Life Sciences Group's current Moat Score of 4 is 100% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SELLAS Life Sciences Group's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SELLAS Life Sciences Group stock overvalued right now?
SELLAS Life Sciences Group (SLS) has a current Moat Score of 4. The current Moat Score is 4 and 100% above the Biotechnology industry median of 2.00. SELLAS Life Sciences Group's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For SELLAS Life Sciences Group (SLS), the current Moat Score is 4 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SELLAS Life Sciences Group Business Description

Other Exchanges RXK3:Germany
Address 7 Times Square, Suite 2503, New York, NY, USA, 10036
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
25GF Score

Get the complete analysis for SLS

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.93
Price